Key result
The Tryton side-branch stent, a dedicated device for coronary bifurcation lesions, shows encouraging early clinical data with very low rates of neointimal proliferation.
The Tryton side-branch stent offers a dedicated approach to coronary bifurcation lesions with promising early results regarding neointimal proliferation.
Answers are grounded in this paper and cite their sources.
Early Tryton data support dedicated bifurcation devices; leaves open need for RCTs to confirm outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bartorelli et al. (2010) conducted a review in Coronary bifurcation lesions. Tryton™ side-branch stent was evaluated on Neointimal proliferation (late loss). The Tryton side-branch stent, a dedicated device for coronary bifurcation lesions, shows encouraging early clinical data with very low rates of neointimal proliferation.
Synapse has enriched 10 related papers. Consider them for comparative context: